全文获取类型
收费全文 | 182957篇 |
免费 | 5961篇 |
国内免费 | 2681篇 |
专业分类
耳鼻咽喉 | 1706篇 |
儿科学 | 6322篇 |
妇产科学 | 2742篇 |
基础医学 | 22049篇 |
口腔科学 | 4502篇 |
临床医学 | 12093篇 |
内科学 | 34436篇 |
皮肤病学 | 3096篇 |
神经病学 | 10511篇 |
特种医学 | 3674篇 |
外国民族医学 | 7篇 |
外科学 | 27095篇 |
综合类 | 12796篇 |
现状与发展 | 8篇 |
一般理论 | 4篇 |
预防医学 | 10144篇 |
眼科学 | 3511篇 |
药学 | 21651篇 |
20篇 | |
中国医学 | 8837篇 |
肿瘤学 | 6395篇 |
出版年
2023年 | 1107篇 |
2022年 | 1705篇 |
2021年 | 3440篇 |
2020年 | 2239篇 |
2019年 | 13532篇 |
2018年 | 13032篇 |
2017年 | 6264篇 |
2016年 | 1924篇 |
2015年 | 2004篇 |
2014年 | 3831篇 |
2013年 | 5845篇 |
2012年 | 3950篇 |
2011年 | 3941篇 |
2010年 | 3277篇 |
2009年 | 3140篇 |
2008年 | 3602篇 |
2007年 | 4660篇 |
2006年 | 4752篇 |
2005年 | 4674篇 |
2004年 | 3643篇 |
2003年 | 3720篇 |
2002年 | 3546篇 |
2001年 | 3431篇 |
2000年 | 3602篇 |
1999年 | 3213篇 |
1998年 | 3223篇 |
1997年 | 2561篇 |
1996年 | 2364篇 |
1995年 | 2747篇 |
1994年 | 2571篇 |
1993年 | 2009篇 |
1992年 | 1593篇 |
1991年 | 1583篇 |
1990年 | 1325篇 |
1989年 | 1032篇 |
1988年 | 1075篇 |
1987年 | 1038篇 |
1985年 | 5468篇 |
1984年 | 7319篇 |
1983年 | 5868篇 |
1982年 | 6295篇 |
1981年 | 5736篇 |
1980年 | 4924篇 |
1979年 | 4984篇 |
1978年 | 4078篇 |
1977年 | 3059篇 |
1976年 | 3538篇 |
1975年 | 2740篇 |
1974年 | 2526篇 |
1973年 | 2231篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
31.
32.
目的为研究DNA条形码技术在中成药鉴定中的应用,以三七片为研究对象,对方法的适用性、专属性与精密度进行考察。方法收集15批次市售三七片样品,考察三七片DNA提取条件,并对"中药材DNA条形码分子鉴定法指导原则"中PCR扩增、序列获得、结果判定等方法适用性进行确认;收集三七、人参、西洋参,制作三七片及其掺伪品,考察方法的专属性和重现性。结果三七片取样量100 mg,56℃水浴8 h所获得DNA的质量浓度平均值为60.7 ng/μL,PCR扩增、序列获得和结果判定均可获成功;三七、人参和西洋参的ITS2序列长度均为230bp,三七与人参、三七与西洋参的序列间均存在7个稳定的SNP位点,自制三七片和掺伪三七片均可成功获得ITS2序列,不同比例三七与人参、三七与西洋参的测序峰图在SNP位点处呈现相应峰高比的SNP套峰具备专属性;重复性、中间精密度和重现性考察符合《中国药典》2015年版(通则9101)相关要求。结论 ITS2序列作为DNA条形码能够稳定、准确鉴定三七片的原料药材,具备良好的专属性和精密度,三七片DNA条形码分子鉴定法将为保障三七片临床用药安全提供新的技术手段,并对《中国药典》其他收载单方制剂的鉴定提供参考。 相似文献
33.
The advent of nanotechnology has revolutionized the way clinicians are treating cancers. Treatment for cancer includes surgery, radiotherapy, hormonal therapy, chemotherapy, and now nano therapy, which could be a possible alternative. This new treatment regime can be beneficial since it shows minimum side effects as compared to other treatment methods. Metallic nanoparticles synthesized through green chemistry by using biological entities minimizes the side effects and enhances the properties of the metal against cancer cells. These green nanoparticles are widely used in research and have shown promising cytotoxic activity against various cancer cell lines. Mechanistically, these nanoparticles can enter the cancer cell and cause cell death by the activation of various molecular pathways such as apoptosis, necrosis and autophagy. This review focuses on the metal nanoparticles (silver, gold and copper) synthesized by the green chemistry approach that have been utilized to study the cancer cell death and we are also discussing the underlying molecular pathways. 相似文献
34.
目的 设计一种多姿态轮椅,以满足下肢功能障碍者的多种使用需求。 方法 针对现有多姿态轮椅结构笨重、驱动冗余等缺点,基于双平行四边形机构,提出一种简单、可靠的多姿态轮椅机构形式。旋转驱动正反转驱动双平行四边形机构带动轮椅各部分运动,实现三姿态变换,其中,椅背和腿托耦合运动实现坐姿与仰卧姿态的变换,椅座和椅背耦合运动实现坐姿与站立姿态的变换。对轮椅进行基于均布载荷的力学分析,计算旋转力矩。 结果 从坐姿变换为仰卧姿态时,驱动力矩随着转动角度的增大而增大,并达到一个峰值;从坐姿变换为站立姿态时,驱动力矩随着转动角度增大而逐渐减小。在Adams软件中进行动力学仿真验证,计算结果与仿真结果基本一致。 结论 该轮椅机构有助于实现多姿态轮椅的轻量化设计,满足智能多功能轮椅的设计需求。 相似文献
35.
Joseph F. Levy Rahul Khairnar Alexander V. Louie Timothy N. Showalter C. Daniel Mullins Mark V. Mishra 《Practical radiation oncology》2019,9(2):e172-e179
Purpose
A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).Methods and Materials
A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.Results
The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.Conclusions
Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making. 相似文献36.
Chu-Chih Chen Yin-Han Wang Wei J. Chen Chao A. Hsiung Yue-Liang Leon Guo Shu-Li Julie Wang 《International journal of hygiene and environmental health》2019,222(6):971-980
IntroductionPrenatal exposure to di(2-ethylhexyl) phthalate (DEHP) has been reported to be associated with adverse effects on neurodevelopment that yield behavior syndromes in young children with an estimated median exposure lower than the currently recommended tolerable daily intake (TDI) and reference dose (RfD).ObjectivesOur aim was to derive the benchmark dose for prenatal exposure to DEHP for the neurodevelopmental health in children.MethodsA total of 122 mother-child pairs from the Taiwan Maternal and Infant Cohort Study were analyzed for the dose-response relationship between maternal exposure to DEHP and children's behavioral syndromes evaluated at 8 years (n = 122, 2009), 11 years (n = 96, 2012), and 14 years (n = 78, 2015) of age. We employed a multivariate regression model to assess the statistical associations between the estimated maternal average daily intake of DEHP and child's individual CBCL scores for boys and girls at each separate age, followed by a mixed model for all the children across three ages accounting for individual variations. We then employed structural equation models by combining the children's specific behavioral problem scores at different ages and obtained a simulated overall latent score in relation to maternal exposure. Based on the established dose-response relationship, we derived the benchmark dose (BMD) and the lower limit (BMDL).ResultsAssociations of maternal DEHP exposure (median 4.54) with the Child Behavior Checklist (CBCL) scores were all significant, except for somatic complaints, adjusting for child's age, gender, IQ, and family income. The BMDL, given a benchmark response of 0.10 (0.05) and a background response of 0.05, was 6.01 (2.16) for an integrated CBCL score.ConclusionsThe current TDI (RfD) of 50 (20) for DEHP might not protect pregnant women for their children from behavioral problems. There remains the lack of comparable toxicological data. Further investigations are needed. 相似文献
37.
38.
39.
40.
目的:探讨补肾活血汤治疗激素性股骨头坏死(steroid-induced osteonecrosis of the femoral head,SONFH)的作用机制。方法:通过中医药整合药理学网络计算研究平台(integrative pharmacology-based network computational research platform of Traditional Chinese Medicine,TCMIP)v2.0预测、筛选补肾活血汤组方中14味中药的作用靶标,通过GeneCards、CTD和OMIM数据库查询SONFH的疾病靶点。根据获取的药物靶标和疾病靶点,进一步利用TCMIP v2.0中医药关联网络分析模块构建"药物靶标-疾病靶点"相互作用网络,根据网络拓扑特征值筛选补肾活血汤治疗SONFH的核心作用靶点。利用GO和KEGG数据库,采用富集算法挖掘上述方剂核心作用靶点的生物学功能和通路信息。结果:共获得891个补肾活血汤药物靶标和365个SONFH疾病靶点。经"药物靶标-疾病靶点"相互作用网络分析,最终筛选出31个补肾活血汤治疗SONFH核心靶点,GO功能分析富集出生物过程532条、分子功能29条,KEGG信号通路富集分析出相关通路共12条,主要涉及炎症免疫调节(chemokine signaling pathway,Toll-like receptor signaling pathway,NOD-like receptor signaling pathway,leukocyte transendothelial migration,Complement and coagulation cascades,cytokine-cytokine receptor interaction)、血管新生及血液循环调节(VEGF signaling pathway)、神经系统调节(neuroactive ligand-receptor interaction)和细胞功能调节(apoptosis,regulation of actin cytoskeleton)等方面。结论:结合SONFH的病理机制,排除缺乏特异性的信号通路,我们推测补肾活血汤可能通过调节TLR4/NF-κB和VEGF信号通路发挥补肾壮骨、活血化瘀的功效,这可能是其治疗SONFH的作用机制之一。 相似文献